Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology
Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a rapid impetus for its use across various inflammatory dermatoses for its selective downstream action on cytokines...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wolters Kluwer Medknow Publications
2024-10-01
|
| Seria: | Indian Dermatology Online Journal |
| Hasła przedmiotowe: | |
| Dostęp online: | https://journals.lww.com/10.4103/idoj.idoj_449_24 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|